• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Collaborative care intervention does not improve health in chronic heart failure, but alleviates depression and fatigue

byAngela ZhangandAnees Daud
March 7, 2018
in Cardiology, Chronic Disease, Psychiatry, Public Health
Reading Time: 3 mins read
Earlier puberty associated with increased risk of depression in girls
Share on FacebookShare on Twitter

1. Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA), a collaborative care intervention combining symptom and psychosocial care, did not improve heart failure-specific health status in chronic heart disease, compared to usual care.

2. When compared to usual care, CASA did improve secondary outcomes of depression and fatigue.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Patients with heart failure experience significant morbidity from symptoms such as breathlessness, fatigue, pain, and depression. Though palliative care is recommended for heart failure patients, the availability of palliative care specialists for the large population of heart failure patients is limited, and interventions that can be integrated earlier and are scalable to a large number of patients are greatly needed. This study assessed the potential benefits of the Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) intervention, which uses nurses and social workers to apply palliative care approaches to treat symptoms and psychosocial care to treat depression. The authors found that compared to usual care, CASA did not differ in improving the Kansas City Cardiomyopathy Questionnaire (KCCQ) score, a measure of heart failure-specific health status. However, the depressive symptoms did improve with CASA over usual care, and there was a temporary improvement in both fatigue and anxiety.

This trial was the first to assess a palliative and psychosocial collaborative care intervention for heart failure patients, and was both randomized and consisted of a large number of patients from a diverse background and health systems. However, it is possible that the sample was not representative of and cannot be generalized to all heart failure patients, and that there was not sufficient power to detect a modest intervention effect.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

Relevant Reading: Defining the role of palliative care in older adults with heart failure.

In-Depth [randomized controlled trial]: This study examined a sample of 314 heart failure patients in 3 health systems (urban safety net, Veterans Affairs, and academically affiliated health systems) identified via electronic health records, and randomized them to receive the CASA intervention or usual care. The CASA intervention included (1) a registered nurse to address symptoms, (2) a social worker to provide structured psychosocial care, and (3) a team including physicians, who reviewed the patient’s care and provided guidance on tests and medications to the patients’ clinicians. On the other hand, usual care involved care at the discretion of their clinicians.

Patients who received CASA did not differ significantly from patients receiving usual care in terms of the KCCQ health status score (score improvement of 5.5 vs. 2.9 points in the CASA and usual care arms, respectively; difference, 2.6; 95% CI, -1.3 to 6.6; p = 0.19). However, depressive symptoms did improve with CASA (effect size of -0.34 at 3 months with p = 0.01; -0.29 at 6 months with p = 0.02). Fatigue and anxiety also improved but did not persist at 12 months. Mortality was similar in both arms (10 of 157 in CASA arm, 13 of 157 in usual care arm, p = 0.52).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: community health workerscongestive heart failuredepressionpalliative care
Previous Post

Physical, physiological benefits of hormonal treatment in gender dysphoria

Next Post

HCV-infected kidney donors could save lives

RelatedReports

Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Increased risk of stillbirth recurrence after a previous stillbirth
Chronic Disease

Physicians slightly more likely to die at home or hospice

February 23, 2026
Next Post
Solitary kidney not associated with contrast-induced nephropathy

HCV-infected kidney donors could save lives

Late gestation antidepressant use linked to postpartum hemorrhage

Sexual minorities more likely to become pregnant as teenagers

Active surveillance in favorable-risk prostate cancer associated with low long-term mortality

Single PSA screening increases prostate cancer detection but does not change mortality

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.